The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension Formulation

NCT02393807 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF 06260414 solid dose formulation
DRUG: PF-06260414 nanosuspension

Sponsor

Pfizer